Effect of Respiratory Muscle Training on Ventilatory Functions of Chronic Obstructive Pulmonary Disease Patinets

Not Applicable

• Conditions: Respiratory; CHRONIC OBSTRUCTIVE PULMONARY DISEASE

• Registration Number: PACTR201802003091341
• Lead Sponsor: non

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-14
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

¿They suffer from 5-year history of chronic obstructive lung disease.
¿Their BMI is from 25 to 34.9 kg/m²
¿Their age range from 40 ¿ 60 years old of both sexes.
¿They are medically controlled.
¿The patients fulfilled the criteria for COPD: the presence of a post bronchodilator FEV1 > 80% predicated together with an FEV1/FVC <0.70 confirm the presence of airflow limitation that is not fully reversible .( Global Initiative for Chronic Obstructive Lung Disease, 2016)
¿GOLD criteria were also followed for staging COPD severity into mild (FEV1>80%, stage I), moderate (FEV1 between 50% and 80%) stage II and Severe (30% ¿ FEV1 < 50% predicted) stage III(Global Initiative for Chronic Obstructive Lung Disease, 2016).

Exclusion Criteria

¿Patients with recent COPD exacerbation
¿Unstable angina
¿Respiratory tract infection within 1 month of the start of the study
¿Myocardial infarction
¿Angioplasty
¿Heart surgery in the previous 3 months
¿Basal blood pressure > 180/100 mmHg, resting pulse rate > 120 bpm
¿Body mass index (BMI) > 35 kg/m2
¿Chronic renal impairments
¿Epistaxis .
¿Active Haemoptysis.
¿Recent facial, oral, or skull surgery or trauma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1 , FEVI/FVC ratio

Secondary Outcome Measures

Name	Time	Method
FVC, PEFR, PIFR , MVV ,Maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax)